Fight Against Coronavirus: Indian Virologist Develops Test Kit, Gives Birth to a Baby Girl the Next Day
Minal Dakhave Bhosale headed the team which developed the test kit for COVID-19 in India.
India, like many countries, around the world has not been able to keep up with mass screening for COVID-19. The situation might change now since a virologist Minal Dakhave Bhosale from Mylab Discovery Pune has developed a test kit for COVID-19. This kit was launched in the market last Thursday. The first batch of 150 kits was shipped to labs on Pune, Mumbai, Delhi, Goa and Bangalore. the second batch was also delivered soon after that. Mylab Discovery specializes in developing the test kits for HIV, Hepatitis B and C, along with other diseases. According to the company, it can produce as much as 200,000 test kits a week if the need arises.
This team was headed by the virologist Minal Dakhave Bhosale who is the research and development chief at Mylab Discovery. But that's not what makes this story so important. As the BBC reported, she was dealing with two deadlines at the same time; both personal and professional. Soon after developing the test kits, she delivered a baby girl.
Here it is also important to note down that the team developed the test kit in a record time of six weeks which would otherwise have taken three to four months. They started working on the test kit in February.
Although Ms Bohosale was struggling with a pregnancy complication at that time, she took the test kit as a challenge and submitted the kit for evaluation to National Institute of Virology. She delivered her daughter just a day after.
The test kit was subjected to various tests before the launch. According to Ms Bhosale, their target was to get 100% accurate results which they succeded in. Many other companies were also working on developing these test kits but Mylab Discovery Pune was the only one to reach 100% test results, as stated by Indian Council for Medical Research which runs the National Institute of Virology. Initially, India was only testing people with a travel history to the highly infected area or those in close contact with an infected person.